Edward J Dulac III insider trades
Open-market stock purchases and sales by Edward J Dulac III, EVP, Chief Financial Officer at Intellia Therapeutics, Inc, from SEC Form 4 filings since Aug 17, 2020.
Open-market stock purchases and sales by Edward J Dulac III, EVP, Chief Financial Officer at Intellia Therapeutics, Inc, from SEC Form 4 filings since Aug 17, 2020.